Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for ImmunityBio (IBRX) over the last 11 years, with Q3 2025 value amounting to $978000.0.

  • ImmunityBio's Amortizatization of Intangibles rose 6862.07% to $978000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 9104.26%. This contributed to the annual value of $5.8 million for FY2024, which is 582.46% down from last year.
  • ImmunityBio's Amortizatization of Intangibles amounted to $978000.0 in Q3 2025, which was up 6862.07% from $11000.0 recorded in Q2 2025.
  • ImmunityBio's Amortizatization of Intangibles' 5-year high stood at $4.3 million during Q4 2024, with a 5-year trough of $11000.0 in Q2 2025.
  • For the 5-year period, ImmunityBio's Amortizatization of Intangibles averaged around $1.2 million, with its median value being $1.3 million (2023).
  • Per our database at Business Quant, ImmunityBio's Amortizatization of Intangibles skyrocketed by 355555.56% in 2021 and then plummeted by 9720.81% in 2025.
  • Quarter analysis of 5 years shows ImmunityBio's Amortizatization of Intangibles stood at $1.4 million in 2021, then increased by 19.36% to $1.7 million in 2022, then dropped by 19.73% to $1.3 million in 2023, then soared by 223.6% to $4.3 million in 2024, then tumbled by 77.21% to $978000.0 in 2025.
  • Its Amortizatization of Intangibles was $978000.0 in Q3 2025, compared to $11000.0 in Q2 2025 and $52000.0 in Q1 2025.